FDA approves Gilead's $1,000-a-day hepatitis C pill
(Reuters) - U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi as a potentially easier cure for chronic infection with the liver-destroy...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/MG0s8NnQEEg/story01.htm
No comments:
Post a Comment